Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder

European Urology

Volumn 67, Issue 2, 2015, Pages 198-201

  Kim, Philip H ^a   Cha, Eugene K ^a   Sfakianos, John P ^a   Iyer, Gopa ^a,b   Zabor, Emily C ^a   Scott, Sasinya N ^a   Ostrovnaya, Irina ^a   Ramirez, Ricardo ^a   Sun, Arony ^a   Shah, Ronak ^a   Yee, Alyssa M ^a   Reuter, Victor E ^a,b   Bajorin, Dean F ^a,b   Rosenberg, Jonathan E ^a,b   Schultz, Nikolaus ^a   Berger, Michael F ^a   Al Ahmadie, Hikmat A ^a   Solit, David B ^a,b   Bochner, Bernard H ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Bladder cancer; Clinical outcomes; Genomics; Mutation; PIK3CA

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE CATALYTIC SUBUNIT ALPHA; PROTEIN KINASE B; PROTEIN P53; UNCLASSIFIED DRUG; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN; TP53 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; BLADDER CARCINOMA; CANCER GENETICS; CANCER GRADING; CANCER PATIENT; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; CANCER SURVIVAL; CHROMATIN; COPY NUMBER VARIATION; CYSTECTOMY; ENZYME ACTIVE SITE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC MARKER; GENOMICS; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MODIFIER GENE; NEXT GENERATION SEQUENCING; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; RECURRENCE FREE SURVIVAL; SURVIVAL PREDICTION; TRANSITIONAL CELL CARCINOMA; CARCINOMA; DISEASE FREE SURVIVAL; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETICS; HIGH THROUGHPUT SEQUENCING; MORTALITY; MULTIVARIATE ANALYSIS; MUTATION; PATHOLOGY; PHENOTYPE; PREDICTIVE VALUE; PROCEDURES; RISK FACTOR; SECONDARY; TIME FACTOR; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE; URINARY BLADDER NEOPLASMS; UROTHELIUM;

BIOMARKERS, TUMOR; CARCINOMA; CYSTECTOMY; DISEASE-FREE SURVIVAL; GENE EXPRESSION PROFILING; GENES, P16; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LYMPHATIC METASTASIS; MULTIVARIATE ANALYSIS; MUTATION; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PHENOTYPE; PHOSPHATIDYLINOSITOL 3-KINASES; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84920655875     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.06.050     Document Type: Article

References (10)

1. Y. Gui, G. Guo, and Y. Huang Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder Nat Genet 43 2011 875 878
2. G. Guo, X. Sun, and C. Chen Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation Nat Genet 45 2013 1459 1463
3. Cancer Genome Atlas Research, Network. Comprehensive molecular characterization of urothelial bladder, carcinoma Nature 507 2014 315 322
4. G. Iyer, H. Al-Ahmadie, and N. Schultz Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer J Clin Oncol 31 2013 3133 3140
5. N. Wagle, M.F. Berger, and M.J. Davis High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing Cancer Discov 2 2012 82 93
6. K. Kalinsky, L.M. Jacks, and A. Heguy PIK3CA mutation associates with improved outcome in breast cancer Clin Cancer Res 15 2009 5049 5059
7. H. Shigaki, Y. Baba, and M. Watanabe PIK3CA mutation is associated with a favorable prognosis among patients with curatively resected esophageal squamous cell carcinoma Clin Cancer Res 19 2013 2451 2459
8. D.A. Solomon, J.S. Kim, and J. Bondaruk Frequent truncating mutations of STAG2 in bladder cancer Nat Genet 45 2013 1428 1430
9. C. Balbas-Martinez, A. Sagrera, and E. Carrillo-de-Santa-Pau Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy Nat Genet 45 2013 1464 1469
10. G. Sjodahl, M. Lauss, and K. Lovgren A molecular taxonomy for urothelial carcinoma Clin Cancer Res 18 2012 3377 3386